Volume : 08, Issue : 05, May – 2021
Title:
18.SYSTEMATIC REVIEW OF COVID-19 MORTALITY IN DIABETIC PATIENTS AND THYROID DISEASE PATIENTS
Authors :
Hanin Abdulkhaliq Almehmadi, Hanan abdulkhailq almehmadi
Abstract :
Introduction: A pneumonia outbreak of unknown etiology occurred in Wuhan, China, in December 2019. The cases were associated with a local seafood market selling live animals, suggesting that the pathogens were transmitted from animals to humans, which soon escalated to human-to-human transmission. This pathogen was identified and named as 2019 novel coronavirus (2019- nCoV) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing diseases named coronavirus disease 2019 (COVID-19). The clinical manifestations of SARS-CoV-2 are very similar to that of SARS, and infected patients may develop acute respiratory distress syndrome (ARDS) and, in the unlikely event, admission to the intensive care unit (ICU) and subsequent mortality. These severe cases are often associated with comorbidities, especially diabetes and others like thyroid disorders.
Aim of the Study: To undertake a systematic review to understand the mortality rate in diabetic and thyroid disease patients suffering from COVID-19 and the possible implication.
Methodology: The systematic review is a comprehensive research of PUBMED from the November 2019 till May 2021. All hospital and community settings were included in study
Conclusion: COVID-19 in patients with already present underlying diseases can have an increased mortality rate if remained unchecked. Various comorbidities increasing the risk of severe illness of COVID-19 are diabetes mellitus, hypertension, cardiovascular diseases, asthma, thyroid disorder. Diabetes mellitus, in association with poor glycemic control, obesity, and complications of diabetes, including renal, cardiac, and peripheral vascular diseases, can be additive risk factors and can be a call for specific attention. Thyroid disorder itself is not associated with increased mortality among COVID-19 patients, but suppression of the immune system may pose a risk.
Cite This Article:
Please cite this article in press Hanin Abdulkhaliq Almehmadi et al., Systematic Review Of Covid-19 Mortality In Diabetic Patients And Thyroid Disease Patients.., Indo Am. J. P. Sci, 2021; 08(05).
Number of Downloads : 10
References:
1. Muniyappa R. & Gubbi. S. (2020). COVID-19 pandemic, coronaviruses, and diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism, 318(5), E736-E741.
2. Rate C. F. (2020). Characteristics of Patients Dying in Relation to COVID-19 in Italy Onder G, Rezza G, Brusaferro S. JAMA Published online March, 23.
3. Novel C. P. E. R. E. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 41(2), 145.
4. Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., … & Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.
5. Chen Y. ,Yang, D., Cheng B., Chen J., Peng A., Yang C. & Huang K. (2020). Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes care, 43(7), 1399-1407.
6. Rao S., Lau A., & So H. C. (2020). Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care, 43(7), 1416-1426.
7. Zhang P., Zhu L., Cai J., Lei F., Qin J. J., Xie J. & Li, H. (2020). Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation research, 126(12), 1671-1681.
8. Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. (2020). Impact of Diabetes in Patients Diagnosed With COVID-19. Frontiers in immunology, 11, 3112.
9. Wang W, Ye YX, Yao H, Sun LQ, Wang AS, Wang ZY.( 2003). Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome. J Chin Antituberculous Assoc, 25:232-4.
10. Desailloud R.& Hober D. (2009). Viruses and thyroiditis: an update. Virology journal, 6(1), 1-14.
11. Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, Villani L, Magri F, Latrofa F, Chiovato L. (2021). Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. Journal of endocrinological investigation. 44(5):1085-90.
12. Giovanella L, Ruggeri RM, Ovčariček PP, Campenni A, Treglia G, Deandreis D. (2021). Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clinical and translational imaging.11:1-8.
13. Speer G, Somogyi P. (2021). Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocrine Journal.68(2):129-36.
14. Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. (2020). Thyrotoxicosis in patients with COVID-19: the THYRCOV study. European journal of endocrinology. 2020 Oct 1;183(4):381-7.
15. Hariyanto TI, Kurniawan A. (2020). Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes & Metabolic Syndrome.14(5):1429.
16. Daraei M, Hasibi M, Abdollahi H, Mirabdolhagh Hazaveh M, Zebaradst J, Hajinoori M, Asadollahi‐Amin A. (2020).Possible role of hypothyroidism in the prognosis of COVID‐19. Internal medicine journal. (11):1410-2.
17. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P.(2020). Impact of COVID-19 on the thyroid gland: an update. Reviews in Endocrine and Metabolic Disorders. 2020 Nov 25:1-3.
18. Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, Ferrante E, Orsi E, Resi V, Longari V, Cuzzocrea M.(2020). SARS-CoV-2-related atypical thyroiditis. The Lancet Diabetes & Endocrinology. 8(9):739-41.
19. Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L. (2020).Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism. European journal of endocrinology. 2020 Jul 1;183(1):G33-9.